Literature DB >> 30998941

Stress responses in stromal cells and tumor homeostasis.

Ilio Vitale1, Gwenola Manic2, Claudia Galassi3, Lorenzo Galluzzi4.   

Abstract

In most (if not all) solid tumors, malignant cells are outnumbered by their non-malignant counterparts, including immune, endothelial and stromal cells. However, while the mechanisms whereby cancer cells adapt to microenvironmental perturbations have been studied in great detail, relatively little is known on stress responses in non-malignant compartments of the tumor microenvironment. Here, we discuss the mechanisms whereby cancer-associated fibroblasts and other cellular components of the tumor stroma react to stress in the context of an intimate crosstalk with malignant, endothelial and immune cells, and how such crosstalk influences disease progression and response to treatment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Hypoxia; Immunosuppressive metabolites; Immunotherapy; Mesenchymal stem cells; Oxidative phosphorylation

Mesh:

Year:  2019        PMID: 30998941     DOI: 10.1016/j.pharmthera.2019.04.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  8 in total

Review 1.  Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.

Authors:  Maria Esperanza Rodriguez-Ruiz; Ilio Vitale; Kevin J Harrington; Ignacio Melero; Lorenzo Galluzzi
Journal:  Nat Immunol       Date:  2019-12-23       Impact factor: 25.606

2.  PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer.

Authors:  Xiaoting Li; Tian Fang; Sen Xu; Ping Jin; Dongchen Zhou; Zhengzheng Wang; Huayi Li; Zongyuan Yang; Gang Chen; Xu Zheng; Yu Xia; Xiao Wei; Zeyu Zhang; Xin Yang; Ya Wang; Qinglei Gao
Journal:  NPJ Precis Oncol       Date:  2021-06-09

Review 3.  Immunological configuration of ovarian carcinoma: features and impact on disease outcome.

Authors:  Jitka Fucikova; An Coosemans; Sandra Orsulic; David Cibula; Ignace Vergote; Lorenzo Galluzzi; Radek Spisek
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

Review 4.  Macrophages and Metabolic Reprograming in the Tumor Microenvironment.

Authors:  Jin Liu; Mingwei Gao; Zhou Yang; Yidan Zhao; Kun Guo; Binwen Sun; Zhenming Gao; Liming Wang
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

Review 5.  Biophysics involved in the process of tumor immune escape.

Authors:  Maonan Wang; Hui Jiang; Xiaohui Liu; Xuemei Wang
Journal:  iScience       Date:  2022-03-19

Review 6.  Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies.

Authors:  Sergi Benavente; Almudena Sánchez-García; Silvia Naches; Matilde Esther LLeonart; Juan Lorente
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

Review 7.  Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.

Authors:  Jiaqi Li; Jie Qing Eu; Li Ren Kong; Lingzhi Wang; Yaw Chyn Lim; Boon Cher Goh; Andrea L A Wong
Journal:  Molecules       Date:  2020-10-20       Impact factor: 4.411

8.  M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.

Authors:  Michal Hensler; Lenka Kasikova; Karel Fiser; Jana Rakova; Petr Skapa; Jan Laco; Tereza Lanickova; Ladislav Pecen; Iva Truxova; Sarka Vosahlikova; Irena Moserova; Ivan Praznovec; Vit Drochytek; Martina Rehackova; Tomas Brtnicky; Lukas Rob; Vladimir Benes; Jelena Pistolic; Ludek Sojka; Ales Ryska; Catherine Sautes-Fridman; Wolf Herve Fridman; Lorenzo Galluzzi; Radek Spisek; Jitka Fucikova
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.